We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bioquell | LSE:BQE | London | Ordinary Share | GB0004992003 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 597.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMBQE
RNS Number : 1384Z
Bioquell PLC
10 March 2017
Bioquell Plc
('Bioquell' or the 'Company')
Grant of Options
Further to the announcement on 24 November 2016, relating to the approval by shareholders of a Performance Share Plan ("PSP"), Bioquell plc (LSE: BQE) announces that nil cost options over 667,000 Ordinary Shares of 10 pence each ('Ordinary Shares') have been granted to Ian Johnson, Executive Chairman. Nil cost options over 90,000 Ordinary Shares have been granted to Michael Roller, Finance Director. A forfeitable shares award of 333,000 Ordinary Shares has been made to Jay LeCoque, Commercial Director.
These grants represent in aggregate approximately 4.95% of the current issued share capital and are in accordance with the rules of the PSP. The options and forfeitable shares shall vest and the options shall become exercisable on a change of control within 3 years of the date of grant at a price of more than GBP2 per share.
Jay LeCoque and Ian Johnson have no further interest in the share capital of the Company. Michael Roller also holds 9,623 Ordinary Shares and has options over a further 317,980 Ordinary Shares at prices between 85p and 92.5p.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Ian Johnson 2 Reason for the notification - Award of options under Performance Share Plan a) Position/status Chairman b) Initial notification /Amendment Initial notification 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Bioquell Plc b) LEI 2138 005 BQVKIZE 84122 a) Description of the financial Options over Ordinary instrument, Shares of GBP0.10 type of instrument GB0004992003 Identification code b) Nature of the transaction Grant of options c) Price(s) and volume(s) Price(s) Volume(s) Nil paid, no exercise price 667,000 d) Aggregated information - Aggregated volume N/A - single transaction - Price e) Date of the transaction 10 March 2017 f) Place of the transaction n/a d) Aggregated information - Aggregated volume N/A - single transaction - Price e) Date of the transaction 10 March 2017 f) Place of the transaction Off market 1 Details of the person discharging managerial responsibilities / person closely associated a) Name Michael Roller 2 Reason for the notification - Award of options under Performance Share Plan a) Position/status Finance Director b) Initial notification /Amendment Initial notification 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Bioquell Plc b) LEI 2138 005 BQVKIZE 84122 a) Description of the financial Options over Ordinary instrument, type of instrument Shares of GBP0.10 Identification code GB0004992003 b) Nature of the transaction Grant of options c) Price(s) and volume(s) Price(s) Volume(s) Nil paid, no exercise price 90,000 d) Aggregated information - Aggregated volume N/A - single transaction - Price e) Date of the transaction 10 March 2017 f) Place of the transaction n/a d) Aggregated information - Aggregated volume N/A - single transaction - Price e) Date of the transaction 10 March 2017 f) Place of the transaction Off market 1 Details of the person discharging managerial responsibilities / person closely associated a) Name Jay LeCoque 2 Reason for the notification - Award of forfeitable shares under Performance Share Plan a) Position/status Commercial Director b) Initial notification /Amendment Initial notification 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Bioquell Plc b) LEI 2138 005 BQVKIZE 84122 a) Description of the financial Options over Ordinary instrument, type of instrument Shares of GBP0.10 Identification code GB0004992003 b) Nature of the transaction Award of forfeitable shares c) Price(s) and volume(s) Price(s) Volume(s) Nil paid, no exercise price 333,000 d) Aggregated information - Aggregated volume N/A - single transaction - Price e) Date of the transaction 10 March 2017 f) Place of the transaction n/a d) Aggregated information - Aggregated volume N/A - single transaction - Price e) Date of the transaction 10 March 2017 f) Place of the transaction Off market
For further information:
Bioquell Plc Ian Johnson, Executive Chairman Tel: +44 (0) 1264 835900 Michael Roller, Finance Director
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHGGUQGWUPMGUU
(END) Dow Jones Newswires
March 10, 2017 05:18 ET (10:18 GMT)
1 Year Bioquell Chart |
1 Month Bioquell Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions